Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cell Death Differ. 2018 Jan;25(1):161-168. doi: 10.1038/cdd.2017.185. Epub 2017 Nov 3.
Mutant p53 proteins impart changes in cellular behavior and function through interactions with proteins that alter gene expression. The milieu of intracellular proteins available to interact with mutant p53 is context specific and changes with disease, cell type, and environmental conditions. Varying conformations of mutant p53 largely dictate protein-protein interactions as different point mutations within protein-coding regions greatly alter the extent and array of gain-of-function (GOF) activities. Given such variables, how can knowledge regarding p53 missense mutations be translated into predicting or altering biologic activity for therapy? How may knowledge regarding mutant p53 functions within certain disease contexts be harnessed to blunt or ablate mutant p53 GOF for therapy? In this article, we review known proteins that interact with mutant p53 and result in the activation of genes that contribute to p53 GOF with particular emphasis on context dependency and an evolving appreciation of GOF mechanisms.
突变型 p53 蛋白通过与改变基因表达的蛋白质相互作用,赋予细胞行为和功能的改变。与突变型 p53 相互作用的细胞内蛋白质的环境是特定的,并随着疾病、细胞类型和环境条件的变化而变化。突变型 p53 的不同构象在很大程度上决定了蛋白质-蛋白质相互作用,因为蛋白质编码区域内的不同点突变极大地改变了获得性功能(GOF)活性的程度和范围。考虑到这些变量,如何将有关 p53 错义突变的知识转化为预测或改变治疗中的生物学活性?如何利用特定疾病环境中突变型 p53 功能的知识来削弱或消除突变型 p53 的 GOF 以进行治疗?在本文中,我们回顾了已知与突变型 p53 相互作用并导致 p53 GOF 相关基因激活的蛋白质,特别强调了上下文依赖性和对 GOF 机制的不断发展的认识。